As of March 23, 2026, Arcutis Biotherapeutics's top three insider holders are Life Sciences Viii, L.P. Frazier (TenPercentOwner, 8.76Mn shares), Bhaskar Chaudhuri (Director, 867.83K shares), Todd Watanabe (See Remarks, 785.96K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Life Sciences Viii, L.P. Frazier | 8,764,232 | 0 | 26 Oct, 2023 | |
| Bhaskar Chaudhuri | 867,826 | 0 | 16 Jun, 2025 | |
| Todd Watanabe | See Remarks | 785,957 | 0 | 03 Mar, 2026 |
| Advisors Llc Orbimed | 0 | 415,142 | 28 Jun, 2022 | |
| David W Osborne | Chief Technical Officer | 268,854 | 0 | 08 Mar, 2023 |
| David Joseph Topper | Chief Financial Officer | 182,774 | 0 | 03 Apr, 2025 |
| Larry Todd Edwards | See Remarks | 175,178 | 0 | 03 Mar, 2026 |
| Matthew Richard Moore | Svp And Chief Business Officer | 145,505 | 0 | 03 May, 2024 |
| Masaru Matsuda | See Remarks | 136,932 | 0 | 03 Mar, 2026 |
| Latha Vairavan | Svp Chief Financial Officer | 87,754 | 0 | 03 Mar, 2026 |
| Patrick Burnett | See Remarks | 80,651 | 0 | 04 Feb, 2026 |
| Kenneth A. Lock | Chief Commercial Officer | 63,429 | 0 | 08 Mar, 2023 |
| Patricia A. Turney | Svp, Operations | 62,862 | 0 | 08 Mar, 2023 |
| Scott L Burrows | Chief Financial Officer | 59,115 | 0 | 08 Mar, 2023 |
| Howard G. Welgus | 49,744 | 0 | 04 Mar, 2026 | |
| Patrick J Heron | 0 | 27,448 | 17 Jun, 2025 | |
| Sue-Jean Lin | 26,735 | 0 | 25 Nov, 2025 | |
| Patrick J Heron | 26,435 | 0 | 16 Jun, 2025 | |
| Todd Franklin Watanabe | See Remarks | 0 | 25,410 | 12 Jun, 2025 |
| Keith R Leonard | 22,123 | 0 | 04 Mar, 2026 | |
| Neha Krishnamohan | 22,123 | 0 | 17 Nov, 2025 | |
| Halley E Gilbert | 22,123 | 0 | 21 Nov, 2025 | |
| Terrie Curran | 17,748 | 0 | 16 Jun, 2025 | |
| John W Smither | Chief Financial Officer | 11,365 | 0 | 15 Feb, 2024 |
| Joseph L Turner | 4,312 | 0 | 03 Jun, 2022 | |
| Amit Munshi | 4,021 | 0 | 08 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Mar, 2026 | Howard G. Welgus | Common Stock | D | 10,000 | $25.65 | 49,744 | D | S |
| 02 Mar, 2026 | Keith R Leonard | Common Stock | A | 27,052 | $8.63 | 49,175 | D | M |
| 02 Mar, 2026 | Keith R Leonard | Common Stock | A | 12,220 | $7.51 | 61,395 | D | M |
| 02 Mar, 2026 | Keith R Leonard | Common Stock | D | 39,272 | $25.39 | 22,123 | D | S |
| 02 Mar, 2026 | Keith R Leonard | Stock Option (right to buy) | D | 27,052 | $0.00 | 0 | D | M |
| 02 Mar, 2026 | Keith R Leonard | Stock Option (right to buy) | D | 12,220 | $0.00 | 0 | D | M |
| 27 Feb, 2026 | Masaru Matsuda | Common Stock | A | 37,000 | $0.00 | 147,003 | D | A |
| 27 Feb, 2026 | Latha Vairavan | Common Stock | A | 27,000 | $0.00 | 90,607 | D | A |
| 27 Feb, 2026 | Todd Watanabe | Common Stock | A | 102,000 | $0.00 | 823,306 | D | A |
| 27 Feb, 2026 | Larry Todd Edwards | Common Stock | A | 30,000 | $0.00 | 178,865 | D | A |
| 27 Feb, 2026 | Masaru Matsuda | Common Stock | D | 3,325 | $27.95 | 143,678 | D | S |
| 02 Mar, 2026 | Latha Vairavan | Common Stock | D | 2,772 | $25.16 | 87,835 | D | S |
| 02 Mar, 2026 | Todd Watanabe | Common Stock | D | 36,281 | $25.16 | 787,025 | D | S |
| 02 Mar, 2026 | Larry Todd Edwards | Common Stock | D | 3,584 | $25.16 | 175,281 | D | S |
| 02 Mar, 2026 | Todd Watanabe | Common Stock | D | 1,068 | $25.91 | 785,957 | D | S |
| 02 Mar, 2026 | Larry Todd Edwards | Common Stock | D | 103 | $25.91 | 175,178 | D | S |
| 02 Mar, 2026 | Masaru Matsuda | Common Stock | D | 6,553 | $25.16 | 137,125 | D | S |
| 02 Mar, 2026 | Latha Vairavan | Common Stock | D | 81 | $25.91 | 87,754 | D | S |
| 27 Feb, 2026 | Larry Todd Edwards | Stock Option (right to buy) | A | 77,000 | $0.00 | 77,000 | D | A |
| 27 Feb, 2026 | Latha Vairavan | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |